Cardinal Health Net Worth 2010-2023 | CAH

Interactive chart of historical net worth (market cap) for Cardinal Health (CAH) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Cardinal Health net worth as of December 04, 2023 is $26.49B.
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $26.485B $205.012B
Cardinal Health Inc. is a nation-wide drug distributor and provider of services to pharmacies, healthcare providers and manufacturers. The company has two reporting segments: Pharmaceutical and Medical. The Pharmaceutical segment is the second largest pharmaceutical distributor in the United States and the largest nuclear pharmacy. Its products and services include pharmaceutical distribution, manufacturer and specialty services, and nuclear and pharmacy services. The Medical segment manufactures products such as single-use surgical drapes, gowns and apparel; exam and surgical gloves; and fluid suction and collection systems and offers sterile and non-sterile procedure kits. These products are sold directly or distributed via third-party sources in the U.S., Canada, Europe, South America and the Asia/Pacific.?
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $68.992B 19.44
McKesson (MCK) United States $61.116B 16.65
West Pharmaceutical Services (WST) United States $25.962B 43.75
Labcorp (LH) United States $18.848B 15.04
Align Technology (ALGN) United States $16.819B 36.85
Cooper (COO) United States $16.755B 28.01
Henry Schein (HSIC) United States $9.006B 13.73
DENTSPLY SIRONA (XRAY) United States $6.934B 17.69
Merit Medical Systems (MMSI) United States $4.270B 24.73
CONMED (CNMD) United States $3.429B 39.68
Patterson (PDCO) United States $2.416B 11.05
STAAR Surgical (STAA) United States $1.576B 71.76
Atrion (ATRI) United States $0.561B 26.37
Lifevantage (LFVN) United States $0.085B 21.45
Pro-Dex (PDEX) United States $0.058B 19.12
Biolase (BIOL) United States $0.003B 0.00